[P26-9] P26-9: Oncologic drugs (5): Pharmacokinetics, TDM practice

[P26-9-9] Tumor suppressor CYLD as a novel prognostic biomarker in primary breast cancer

Hirofumi Jono¹, Mitsuhiro Hayashi², Satoru Shinriki³, Chika Hirai⁴, Yukio Ando⁵, Hirotaka Iwase⁶, Hideyuki Saito⁷ (1.Kumamoto University Hospital, 2.National Cancer Center, 3.Kumamoto University Hospital, 4.Kumamoto University, 5.Kumamoto University, 6.Kumamoto University, 7.Kumamoto University Hospital)

Keywords:Cylindromatosis (CYLD), Breast cancer, Prognostic biomarker, Nuclear factor-κB (NF-κB)